AstraZeneca’s antiviral drug has proven effective in neutralizing the “Omicron” mutant of corona, including the newer BA.
Data from the Washington University School of Medicine showed that AstraZeneca’s Evusheld was effective at reducing viral load and inflammation in the lungs caused by variants BA.1, BA.1.1, and BA.2. The study was done on mice infected with the virus.
Michael Diamond, professor of biology, pathology and immunology at the University of Washington, said: “The results show that Evusheld’in shows that it is effective in protecting against infection in the lungs, which is a serious disease site for Covid-19 in all ‘Omicron’. ‘ subvariables on infected mice test was done. virus.”
In response, AstraZeneca Vice President John Perez said, “The results also help Evusheld’in”It also supports a potentially important option to help protect vulnerable patients, such as those with compromised immune systems, who could face dire consequences if they contract COVID-19.”
Source: Hill
The Content is sourced from RT News (rt.com); each piece of Content all the Copyrights and Trademarks belong to their Rightful Owners and all Materials to their Authors. We have just Modified and Rearranged that in our platform for our readers.
